RenovoRx, Inc. Share Price
NASDAQ: RNXT | Micro CapRenovoRx, Inc. Stock Performance
RenovoRx, Inc. Share Price Today
As of 29 October 2026, RenovoRx, Inc.'s share price is $1.49. The stock opened at $1.48, compared to its previous close of $1.42. During today's trading session, RenovoRx, Inc.'s share price traded between $1.47 and $1.51, with an average price of $1.49. Over the past 52 weeks, the stock has recorded a high of $2.57 and a low of $0.70. In terms of performance, RenovoRx, Inc.'s share price has risen by 73.68% over the last six months and is up 34.39% on a year-on-year basis.
RenovoRx, Inc. Share Price Chart
RenovoRx, Inc. Quarterly Profit & Loss
All figures in USD
RenovoRx, Inc. Annual Profit & Loss
All figures in USD
About RenovoRx, Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
RenovoRx, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.54 | $1.48 | -5.45% |
Sep 2026 | $1.94 | $1.56 | +6.12% |
Aug 2026 | $0.96 | $1.47 | +53.13% |
Jul 2026 | $0.97 | $0.96 | -2.44% |
Jun 2026 | $0.92 | $0.98 | +8.01% |
May 2026 | $0.88 | $0.91 | +6.55% |
Apr 2026 | $1.02 | $0.85 | -16.18% |
Mar 2026 | $0.90 | $1.02 | +15.91% |
Feb 2026 | $1.03 | $0.88 | -15.38% |
Jan 2026 | $0.86 | $1.04 | +23.22% |
Dec 2025 | $0.89 | $0.84 | -6.22% |
Nov 2025 | $1.07 | $0.90 | -18.55% |